Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly

Blacksmith Medicines, a spin-out of Forge Therapeutics, is pioneering a novel metalloenzyme chemistry platform to create new immuno-oncology and inflammation medicines Research collaboration combines Blacksmith's innovative chemistry platform with Lilly... Biopharmaceuticals, Venture Capital Blacksmith Medicines, Eli Lilly, Forge Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news